You are here

COVID-19-related application for consent to supply goods that do not conform with Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines - section 14/14A

11 May 2021

The COVID-19 pandemic has placed unprecedented pressures and challenges on the pharmaceutical industry, including difficulty in implementing the new medicine labels that comply with the new labelling orders (TGO 91/92) for medicines that came into force on 1 September 2020.

In recognition of these challenges, the Therapeutic Goods Administration (TGA) established a temporary process for sponsors of listed, registered complementary, and over-the-counter (OTC) medicines to request consent to supply products that do not comply with TGO 92 due to adverse business impacts of COVID-19. The end date for this consent was 6 March 2021.

For more information, see: COVID-19 and eligibility to request consent to supply therapeutic goods that do not comply with the new labelling requirements of TGO 92